Back to results
US 2003/0203403 A1Published application
Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
AssigneePharmacia & Upjohn Company
InventorsMatthew L. Peach, Alice L. Laborde
Life of this patent
Estimating the term…
Abstract
The present invention provides for a polypeptide aggregation screening assay for the purpose of detecting modulators of polypeptide aggregation, which can provide for new therapies in pathologic states associated with polypeptide aggregation, especially considered is Alzheimer's Disease.
Claims17
A method for identifying modulators of polypeptide aggregation comprising:
- i) providing a substrate attached to a first binding partner, wherein the first binding partner binds with a second binding partner;
- ii) providing a polypeptide composition comprising polypeptide monomers, wherein at least some of the monomers are modified to comprise the second binding partner;
- iii) incubating the polypeptide composition in the presence and absence of a test agent, under conditions in which the polypeptide monomers aggregate into multimers
- iv) contacting the polypeptide composition to the substrate attached to the first binding partner;
- and
- v) measuring polypeptide aggregation by detecting polypeptide aggregates bound to the substrate, wherein the detecting comprises measuring the second binding partner, and wherein differential polypeptide aggregation in the presence versus the absence of a test agent identifies the test agent as a modulator compound.
3 more elements
Dependencies are inferred from the claim text.